7-氯-1-苯基-3,4-二氢异喹啉 | 104576-30-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氢异喹啉
• 中文名称: 7-氯-1-苯基-3,4-二氢异喹啉
• 英文名称: 7-chloro-1-phenyl-3,4-dihydroisoquinoline
• 英文别名: 1-phenyl-7-chloro-3,4-dihydroisoquinoline
• CAS: 104576-30-9
• 化学式: C₁₅H₁₂ClN
• 分子量: 241.72
• InChiKey: PNWVMSKFQSFCFB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  12.4
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  7-氯-1-苯基-3,4-二氢异喹啉 在 苄基三乙基氯化铵 sodium hydroxide 、 potassium acetate 作用下， 反应 10.0h， 生成 2-acetyl-1,1,5-trichloro-3-phenyl-1a,2,3,7b-tetrahydro-1H-cyclopropisoquinoline
  参考文献：
  名称：

  Synthesis of 1-phenyl-5H-2-benzazepines by ring expansion of 1-phenyl-1,2-dihydroisoquinolines

  摘要：

  DOI：

  10.1021/jo00372a009
• 作为产物：
  描述：

  4-氯苯乙胺 在 四磷十氧化物 、 磷酸 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 1.17h， 生成 7-氯-1-苯基-3,4-二氢异喹啉
  参考文献：
  名称：

  氨基甲酸酯活化率的提高使得能够合成四环苯并内酰胺：8-氧代berbines及其5和7元C环同系物

  摘要：

  开发了直接酰胺化芳族环系N-氨基甲酰基四氢异喹啉底物的途径。该途径使人们能够普遍获得8-氧小ber碱及其5和7元C环同系物。它克服了导致异喹啉主链破坏的不希望的串联副反应，这种副反应在我们先前报道的超酸性氨基甲酸酯活化方法下不可避免地发生。

  DOI：

  10.1039/d0ob02096f

文献信息

• One-Pot N-Deprotection and Catalytic Intramolecular Asymmetric Reductive Amination for the Synthesis of Tetrahydroisoquinolines
  作者：Huan Zhou、Yuan Liu、Suhua Yang、Le Zhou、Mingxin Chang

  DOI：10.1002/anie.201611181

  日期：2017.3.1

  A one‐pot N‐Boc deprotection and catalytic intramolecular reductive amination protocol for the preparation of enantiomerically pure tetrahydroisoquinoline alkaloids is described. The iodine‐bridged dimeric iridium complexes displayed superb stereoselectivity to give tetrahydroisoquinolines, including several key pharmaceutical drug intermediates, in excellent yields under mild reaction conditions.

  描述了用于制备对映体纯的四氢异喹啉生物碱的一锅法N-Boc脱保护和催化分子内还原胺化协议。碘桥联的二聚铱络合物显示出极好的立体选择性，可在温和的反应条件下以优异的收率得到四氢异喹啉，包括几种关键的药物中间体。三种添加剂在该反应中起重要作用：异丙氧基钛（IV）和分子碘促进了中间体亚胺向四氢异喹啉产物的转化；对甲苯磺酸有助于立体控制。
• A Method for Bischler–Napieralski-Type Synthesis of 3,4-Dihydroisoquinolines
  作者：Lin Min、Weiguang Yang、Yunxiang Weng、Weiping Zheng、Xinyan Wang、Yuefei Hu

  DOI：10.1021/acs.orglett.9b00534

  日期：2019.4.19

  s was developed by a Tf2O-promoted tandem annulation from phenylethanols and nitriles. Its success was mainly due to the fact that a phenonium ion was formed in the process and practically functioned as a stable and reactive primary phenylethyl carbocation.

  一种由Tf 2 O促进的由苯乙醇和腈进行的串联环化反应，开发了Bischler-Napieralski型合成3,4-二氢异喹啉的新方法。它的成功主要是由于在该过程中形成了ion离子，并且实际上起了稳定和反应性的伯苯基乙基碳正离子的作用。
• Solvent-promoted highly selective dehydrogenation of tetrahydroisoquinolines without catalyst and hydrogen acceptor
  作者：Guang-Shou Feng、Yue Ji、Hui-Fang Liu、Lei Shi、Yong-Gui Zhou

  DOI：10.1016/j.tetlet.2016.01.008

  日期：2016.2

  An unusual solvent DMF-promoted dehydrogenation of 1-substituted 1,2,3,4-tetrahydroisoquinolines to synthesize cyclic imines is described. This environmentally friendly reaction features no requirement of any metal catalysts, oxidants, or hydrogen acceptors. A wide range of structurally varied 3,4-dihydroisoquinolines can be obtained with good yields and excellent chemoselectivities.

  描述了一种不寻常的溶剂DMF促进的1-取代的1,2,3,4-四氢异喹啉脱氢反应，合成环亚胺。这种对环境友好的反应不需要任何金属催化剂，氧化剂或氢受体。可以以良好的产率和优异的化学选择性获得各种结构变化的3，4-二氢异喹啉。
• Studies on Cerebral Protective Agents. IX. Synthesis of Novel 1,2,3,4-Tetrahydroisoquinolines as N-Methyl-D-aspartate Antagonists.
  作者：Mitsuru OHKUBO、Atsushi KUNO、Kiyotaka KATSUTA、Yoshiko UEDA、Kiyoharu SHIRAKAWA、Hajime NAKANISHI、Isao NAKANISHI、Takayoshi KINOSHITA、Hisashi TAKASUGI

  DOI：10.1248/cpb.44.95

  日期：——

  A series of 1,2,3,4-tetrahydroisoquinoline derivatives were synthesized and evaluated for anticonvulsant activity against intracerebro-ventriculas (i.c.v.) N-methyl-D-aspartate (NMDA)-induced seizures in mice. Among these compounds, (+)-1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride ((+)-1a, FR115427) was the most effective anticonvulsant, and also protected CA1 hippocampal neurons

  合成了一系列的1,2,3,4-四氢异喹啉衍生物，并评估了其对小鼠脑室内（icv）N-甲基-D-天冬氨酸（NMDA）诱导的惊厥的抗惊厥活性。在这些化合物中，（+）-1-甲基-1-苯基-1,2,3,4-四氢异喹啉盐酸盐（（+）-1a，FR115427）是最有效的抗惊厥药，也可以保护CA1海马神经元免受缺血-诱导大鼠在32 mg / kg ip时神经元变性。此外，（+）-1a在3.2-32 mg / kg ip时在小鼠中表现出抗缺氧活性。确定异喹啉环C-1位置的绝对构型为通过（+）-1a（+）-二-对甲苯甲酰基-D-酒石酸酯的单晶X射线分析确定S为S. 讨论了有关该系列化合物抗惊厥活性的构效关系，
• Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor
  作者：Karen R. Romines、George A. Freeman、Lee T. Schaller、Jill R. Cowan、Steve S. Gonzales、Jeffrey H. Tidwell、Clarence W. Andrews、David K. Stammers、Richard J. Hazen、Robert G. Ferris、Steven A. Short、Joseph H. Chan、Lawrence R. Boone

  DOI：10.1021/jm050670l

  日期：2006.1.1

  Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human immunodeficiency virus (HIV). This is particularly true for the growing number of patients infected with virus resistant to currently approved HIV drugs. Our high throughput screening effort identified a benzophenone template as a potential nonnucleoside reverse transcriptase inhibitor (NNRTI). This manuscript describes our extensive exploration of the benzophenone structure-activity relationships, which culminated in the identification of several compounds with very potent inhibition of both wild type and clinically relevant NNRTI-resistant mutant strains of HIV. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC50 values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies.